SCHEMBL29083576

SCHEMBL29083576

CCOC(=O)c1cc(NC(C)C)cc(Br)n1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CYP1A2 P05177 2/20 0.43
S1PR2 O95136 1/20 0.38
MAPT P10636 6/20 0.38
RAB9A P51151 3/20 0.38
POLB P06746 3/20 0.38
NPC1 O15118 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
PKM P14618 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
THRB P10828 1/20 0.37
CYP2C19 P33261 1/20 0.37
SLC2A1 P11166 1/20 0.37
MAPK1 P28482 1/20 0.37
KDM4E B2RXH2 3/20 0.37
DHODH Q02127 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3087925 0.74 RAB9A (0.48) ALDH1A1SMN1; SMN2CYP1A2RAB9APOLB
SCHEMBL7753230 0.74 CYP1A2 (0.51) ALDH1A1SMN1; SMN2CYP1A2MAPTRAB9A
SCHEMBL841568 0.72 CYP1A2 (0.61) ALDH1A1SMN1; SMN2CYP1A2MAPTRAB9A
SCHEMBL3093655 0.70 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2CYP1A2MAPTRAB9A
SCHEMBL17595322 0.69 CYP1A2 (0.58) ALDH1A1SMN1; SMN2CYP1A2MAPTRAB9A
SCHEMBL1424967 0.69 CYP1A2 (0.49) ALDH1A1SMN1; SMN2CYP1A2S1PR2MAPT
SCHEMBL3443140 0.69 CA12 (0.58) SMN1; SMN2CYP1A2RAB9ANPC1NPSR1
SCHEMBL3369232 0.69 NLRP3 (0.56) ALDH1A1SMN1; SMN2CYP1A2MAPTRAB9A
SCHEMBL6509026 0.69 TAS1R3 (0.46) CYP2C19
SCHEMBL12853621 0.69 CYP1A2 (0.49) ALDH1A1SMN1; SMN2CYP1A2S1PR2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116867758-A IRAK degradation agents and uses thereof 凯麦拉医疗公司 2023-10-10 CN disclosed
CN-116669722-A Interleukin-1 receptor-related kinase (IRAK) degradants and uses thereof 凯麦拉医疗公司 2023-08-29 CN disclosed